comparing efficacy of dexmedetomidine as an add on drug to levobupivacaine when injected near a nerve versus when dexmedetomidine given intravenous and levobupivacaine given near nerve in ultrasound guided Supraclavicular Brachial Plexus Block in Upper Limb Surgeries

Comparing Efficacy Of Perineural Versus Intravenous Dexmedetomidine as an Adjuvant to 0.5 % Levobupivacaine in ultrasound guided Supraclavicular Brachial Plexus Block in Upper Limb Surgeries in Department of Anaesthesia at SMS Hospital ,Jaipur - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061745

Enrollment

100

Registered

2024-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Perineural dexmedetomidine with 0.5% levobupivacaine: patients will receive 25 ml 0.5% Levobupivacaine and 1mcg/kg Dexmedetomidine diluted in 2ml NS for ultrasound guided supraclavicula

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Patients who Will give informed written consent Either sex American Society of Anesthesiologists Physical Status (ASA-PS) Classes I and II Posted for upper limb surgeries Body weight :– 40-70 kg

Exclusion criteria

Exclusion criteria: Patients having severe systemic illness and bleeding disorders, Pregnant women Patients allergic to study drugs Patients having peripheral neuropathy or motor neuron disorders Patients having pathology at infection site Disability limiting the preferences of block

Design outcomes

Primary

Measure	Time frame
To assess and compare the difference in mean duration of analgesia in both the groups.Timepoint: 0,5,10,15,20,25,30,45,60,75,90 minutes	—

Secondary

Measure	Time frame
Onset of sensory block (minutes) Onset of motor block (minutes) Duration of motor block (minutes) Mean systolic B.P, Mean diastolic B.P, Mean of mean B.P Mean heart rate Proportion of adverse effects if any in both the groups.Timepoint: 0,5,10,15,20,25,30,45,60,75,90 minutes	—

Countries

India

Contacts

Public ContactSantosh Kanwar

Sawai Man Singh Medical College

poonamkalra24@gmail.com9413416787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026